Robert Langer

Institute Professor and Professor of ChemE & BE

Department
Office of the Institute Professors
Technology Areas
Biotechnology: DNA & RNA Editing, Biomedical Devices & Systems, Cell Separation, Sensors & Monitoring, Biomanufacturing, Tissue Engineering, Prostheses, Synthetic Biology / Chemicals & Materials: Catalysis & Synthesis, Nanotechnology & Nanomaterials, Polymers, Composites / Drug Discovery and Research Tools: Genomics & Proteomics, Cell Interrogation, Cell Lines & Organoids, Cell Culture, Animal Models / Therapeutics: Nucleic Acids, Cell Based Therapy, Regenerative Medicine, Small Molecules, Proteins & Antibodies, Vaccines / Drug Delivery: Microparticles & Nanoparticles, Vectors & Virus like Particles / Biomaterials & Bioelectronics: Health Monitoring, Medical Device Coatings, Tissue Repair / Communication Systems: Wireless / Artificial Intelligence (AI) and Machine Learning (ML) / Sensing & Imaging: Imaging, Chemical & Radiation Sensing / Agriculture & Food: Delivery, Nutrition / Electronics & Photonics: Semiconductors, Quantum Technology, Photonics / Industrial Engineering & Automation: Robotics / Computer Science: Bioinformatics / Energy & Distribution: Electrochemical Devices / Diagnostics: Imaging Agents, Assays

Prolific, award-winning pioneer of new technologies known for revolutionary contributions to the fields of medicine and biotechnology.

Background and Experience

Dr. Langer is one of nine Institute Professors at MIT – the highest honor that can be awarded to a faculty member. He has written more than 1,570 articles and has over 1,400 issued and pending patents worldwide. Dr. Langer’s patents have been licensed or sublicensed to over 400 pharmaceutical, chemical, biotechnology, and medical device companies. He is the most cited engineer in history and was named as one of the 25 most important individuals in biotechnology in the world by Forbes Magazine (1999) and Bio World (1990).

Dr. Langer is one of three living individuals to have received both the United States National Medal of Science (2006) and the United States National Medal of Technology and Innovation (2011). In 1998, he was recognized as “one of history’s most prolific inventors in medicine”, receiving the Lemelson-MIT prize – the world's largest prize for invention. He is the director of the word's largest biomedical engineering lab whose research focuses on the interface of biotechnology and materials science.

Dr. Langer received his Bachelor’s Degree from Cornell University in 1970 and his Sc.D. from the Massachusetts Institute of Technology in 1974, both in Chemical Engineering.

You have to realize that failure is OK. If you want to change the world, you have to be prepared to fail. You put your head down and keep going. ”
Robert Langer

Awards and Honors

Dr. Langer has received over 220 major awards including:

  • 41 honorary doctorates
  • Charles Stark Draper Prize | 2002
  • Albany Medical Center Prize in Medicine and Biomedical Research | 2005
  • Induction into the National Inventors Hall of Fame (2006)
  • Queen Elizabeth Prize for Engineering | 2015
  • Balzan Prize for Biomaterials for Nanomedicine and Tissue Engineering | 2022

Technologies

Methods for Cell Separation and Cytometry Based on Directed Cell Rolling on Patterned Substrates

Technology / Case number: #12899
Jeffrey Michael Karp / Seungpyo Hong / Rohit N Karnik / Ying Mei / Suman Bose / Robert Langer / Daniel Anderson
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Thiol-yne Mediated Synthesis of Multi-Tailed Lipids for siRNA Delivery

Technology / Case number: #15846
Kevin Love / Akinleye Alabi / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Injectable Hydrogel and Uses Thereof

Technology / Case number: #16662J
Yizhou Dong / Benjamin Tang / Kun Xue / Matthew Webber / Omid Veiseh / Weiheng Wang / Eric Appel / Robert Langer / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery
License

Zwitterionic Polymer Functionalized Lipid Nanoparticles for Delivery of mRNA

Technology / Case number: #24662
Robert Langer / Allen Jiang / Sushil Lathwal / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Robocap

Technology / Case number: #24836J
Giovanni Traverso / Shriya Sruthi Srinivasan / Robert Langer / Amro Alshareef
Technology Areas: Biomaterials & Bioelectronics / Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Glucose- Responsive Microgels for Closed Loop Insulin Delivery

Technology / Case number: #15057J
Zhen Gu / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials
License

Oligomeric Conjugates for siRNA Delivery and Glucose-Responsive Insulins

Technology / Case number: #15977J
Arturo Vegas / Rosemary Kanasty / Robert Langer / Daniel Anderson
Technology Areas: Diagnostics / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Long-term Stabilization, Formulation and Tableting of Live Microbial Cells

Technology / Case number: #22886J
Giovanni Traverso / Robert Langer / Miguel Jimenez / Johanna L'Heureux / Emily Kolaya
Technology Areas: Drug Discovery and Research Tools
Impact Areas: Healthy Living
License

Vibrating Ingestible BioElectronic Stimulator (VIBES)

Technology / Case number: #23759JQ
Giovanni Traverso / Shriya Sruthi Srinivasan / Robert Langer / Amro Alshareef
Technology Areas: Biomaterials & Bioelectronics / Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Ingestible Electronics Integrated with Flexible Measurement Electrodes for Gastrointestinal Bioelectric Sensing

Technology / Case number: #23241J
Giovanni Traverso / Robert Langer / Sean You / So-Yoon Yang / Adam Gierlach / George Selsing
Technology Areas: Biomaterials & Bioelectronics / Biotechnology / Computer Science
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.